Discovery of precision targeting EZH2 degraders for triple-negative breast cancer
Cheng Wang, Xinye Chen, Xingchen Liu, Dehua Lu, Shang Li, Lailiang Qu, Fucheng Yin, Heng Luo, Yonglei Zhang, Zhongwen Luo, Ningjie Cui, Lingyi Kong, Xiaobing Wang
Topics & Concepts
EZH2Triple-negative breast cancerChemistryCancer researchPRC2ApoptosisCancer cellIC50CancerBreast cancerBiochemistryIn vitroBiologyMedicineInternal medicineEpigeneticsGeneProtein Degradation and InhibitorsEpigenetics and DNA MethylationCancer-related gene regulation